218 related articles for article (PubMed ID: 29506598)
1. Headache in Guillain-Barré Syndrome: Diagnostic and Management Implications.
Alrohimi A; Jassal R
Can J Neurol Sci; 2018 Mar; 45(2):240-242. PubMed ID: 29506598
[TBL] [Abstract][Full Text] [Related]
2. Headache and Pain in Guillain-Barré Syndrome.
Farmakidis C; Inan S; Milstein M; Herskovitz S
Curr Pain Headache Rep; 2015 Aug; 19(8):40. PubMed ID: 26122532
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Koichihara R; Hamano S; Yamashita S; Tanaka M
Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
[TBL] [Abstract][Full Text] [Related]
4. Headache and intracranial hypertension in Guillain-Barré syndrome: a case report and literature review.
Wang T; Wang Z; Guo Z
Int J Neurosci; 2019 Dec; 129(12):1179-1182. PubMed ID: 31317792
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome.
Bavikatte G; Gaber T; Eshiett MU
J Clin Neurosci; 2010 Jul; 17(7):924-6. PubMed ID: 20409715
[TBL] [Abstract][Full Text] [Related]
6. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.
Chakraborty T; Kramer CL; Wijdicks EFM; Rabinstein AA
Neurocrit Care; 2020 Feb; 32(1):113-120. PubMed ID: 31297663
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome in Guillain-Barré syndrome.
Chen A; Kim J; Henderson G; Berkowitz A
J Clin Neurosci; 2015 May; 22(5):914-6. PubMed ID: 25800144
[TBL] [Abstract][Full Text] [Related]
8. [Posterior reversible encephalopathy syndrome during intravenous immunoglobulin therapy in Guillain-Barré syndrome].
Watanabe E; Ido N; Saito T; Kato H; Terashi H; Aizawa H
Rinsho Shinkeigaku; 2021 Jan; 61(1):12-17. PubMed ID: 33328417
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy in a GT1a positive oculopharyngeal variant of Guillain-Barré syndrome: A case-report and review of the literature.
Xiromerisiou G; Kalampokini S; Rikos D; Provatas A; Tsouris Z; Markou K; Ralli S; Dardiotis E
Clin Neurol Neurosurg; 2020 Sep; 196():106037. PubMed ID: 32623212
[TBL] [Abstract][Full Text] [Related]
10. Reversible cerebral vasoconstriction in Guillain-Barré syndrome.
Wei DY; Kao J; Wu TY; Pereira JA; Anderson NE; Alan Barber P
J Clin Neurosci; 2015 Jul; 22(7):1201-2. PubMed ID: 25778383
[TBL] [Abstract][Full Text] [Related]
11. Reversible cerebral vasoconstriction syndrome in Guillain-Barre syndrome: a case report and literature review.
Seok HY; Eun MY; Kim S; Lee JJ; Oh GR; Kim GY; Sohn SI
Neurol Sci; 2024 Jan; 45(1):101-107. PubMed ID: 37676373
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome.
Etxeberria A; Lonneville S; Rutgers MP; Gille M
Rev Neurol (Paris); 2012 Mar; 168(3):283-6. PubMed ID: 22318132
[TBL] [Abstract][Full Text] [Related]
13. Headache and Papilledema in Guillain-Barré Syndrome.
Alrohimi A; Ba F
Can J Neurol Sci; 2018 May; 45(3):351-353. PubMed ID: 29374500
[No Abstract] [Full Text] [Related]
14. Guillain-Barré Syndrome Complicated by Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.
Kobayashi H; Hoshina Y; Higa H; Watari T
Eur J Case Rep Intern Med; 2023; 10(10):003949. PubMed ID: 37789979
[TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome associated with Guillain-Barré syndrome: Case report and clinical management considerations.
Salvalaggio A; Cagnin A; Marson P; Ferracci F; Cortelli P; Corbetta M; Briani C
J Clin Apher; 2020 Jun; 35(3):231-233. PubMed ID: 32289176
[TBL] [Abstract][Full Text] [Related]
16. Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: a case report.
Schreiber AL; Norbury JW; De Sousa EA
Ann Phys Rehabil Med; 2011 Nov; 54(8):519-24. PubMed ID: 22036304
[TBL] [Abstract][Full Text] [Related]
17. Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.
Sutter R; Mengiardi B; Lyrer P; Czaplinski A
Neuromuscul Disord; 2009 Oct; 19(10):709-10. PubMed ID: 19616949
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barre variant in the deployed setting.
Chalela JA
Mil Med; 2013 Oct; 178(10):e1156-8. PubMed ID: 24083932
[TBL] [Abstract][Full Text] [Related]
19. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes.
Tatsumoto M; Misawa S; Kokubun N; Sekiguchi Y; Hirata K; Kuwabara S; Yuki N
Muscle Nerve; 2015 Jun; 51(6):811-4. PubMed ID: 25287079
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
